p34cdc2 in invasive breast cancer:: relationship to DNA content, Ki67 index and c-erbB-2 expression

被引:0
|
作者
Wiesener, B
Hauser-Kronberger, CE
Zipperer, E
Dietze, O
Menzel, C
Hacker, GW
机构
[1] Gen Hosp, St Johanns Spital, Inst Pathol Anat, A-5020 Salzburg, Austria
[2] Gen Hosp, St Johanns Spital, Dept Gynecol & Obstet, A-5020 Salzburg, Austria
关键词
c-erbB-2; DNA ploidy; invasive mammary carcinoma; Ki67; p34(cdc2);
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: One-hundred and eighty-eight cases of human mammary carcinoma were examined immunohistochemically for their expression of Ki67, p34(cdc2) and c-erbB-2. DNA image cytometry was performed to evaluate DNA ploidy, Auer type, S-phase fraction (SPF), 5c exceeding rate (5cER) and 2c deviation index (2cDI). Methods and results: One-hundred and sixty-eight cases were invasive ductal carcinomas, 20 were of invasive lobular type. Routinely assessed oestrogen and progesterone receptor scores were available, The results were analysed statistically in comparison to tumour type, histopathological grade, lymph node status, menopausal status, patient age and overall survival. Ki67 (P<0.002) and c-erbB-2 (P<0.0001) correlated well with overall survival (P<0.0008) and grade (P<0.038) but not: with lymph node status and tumour type. p34cdc2 showed a trend towards a positive correlation with Ki67 (P<0.058) and a significant negative correlation with receptor status (P<0.008) but with none of the other parameters examined. Conclusions: No association between the DNA measured parameters (Auer type, SPF, 5cER and 2cDI) and survival was found. Our results suggest that c-erbB-2 and Ki67 are parameters which might, in combination with receptor status, help to define subgroups with different outcomes.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 50 条
  • [1] Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma
    Zheng, Yao
    Wang, Lin
    Zhang, Jian-Ping
    Yang, Jing-Yan
    Zhao, Zhu-Mei
    Zhang, Xiao-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (03) : 339 - 344
  • [2] Expression of p53,c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma
    Yao Zheng
    Department of Pathology
    World Journal of Gastroenterology, 2010, 16 (03) : 339 - 344
  • [3] RELATIONSHIP BETWEEN EGF-R, C-ERBB-2 PROTEIN EXPRESSION AND KI67 IMMUNOSTAINING IN BREAST-CANCER AND HORMONE SENSITIVITY
    NICHOLSON, RI
    MCCLELLAND, RA
    FINLAY, P
    EATON, CL
    GULLICK, WJ
    DIXON, AR
    ROBERTSON, JFR
    ELLIS, IO
    BLAMEY, RW
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (07) : 1018 - 1023
  • [4] EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF P53, KI67 C-ERBB-2 IN PROSTATE CARCINOMAS
    KRISHNA, M
    KHAN, A
    WODA, B
    MENON, M
    MALHOTRA, R
    LABORATORY INVESTIGATION, 1995, 72 (01) : A79 - A79
  • [5] Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours
    Bottini, A
    Berruti, A
    Bersiga, A
    Brunelli, A
    Brizzi, MP
    DiMarco, B
    Cirillo, F
    Bolsi, G
    Bertoli, G
    Alquati, P
    Dogliotti, L
    ANTICANCER RESEARCH, 1996, 16 (5B) : 3105 - 3110
  • [6] Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma
    Tavangar, Seyed Mohammad
    Shojaee, Ali
    Tabriz, Hedieh Moradi
    Haghpanah, Vahid
    Larijani, Bagher
    Heshmat, Ramin
    Lashkari, Anahita
    Azimi, Sima
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (05) : 305 - 309
  • [7] CORRELATION BETWEEN C-ERBB-2, KI67 AND NM23 GENE EXPRESSION AND AXILLARY LYMPH NODE METASTASIS IN BREAST CANCER
    Pu, Yan
    Zou, Qingwei
    Shang, Zhongming
    Yang, Zhongming
    ACTA MEDICA MEDITERRANEA, 2019, 35 (05): : 2799 - 2803
  • [8] Ki67 and c-erbB-2 expression predict response to chemoradiotherapy (CT-RT) in patients (pts) with locally invasive transitional bladder cancer (TBC)
    Naldi, N
    Crafa, P
    Nizzoli, R
    Pajetta, V
    Monica, B
    Potenzoni, D
    Fumagalli, M
    Beretta, M
    Camisa, R
    Passalacqua, R
    ANNALS OF ONCOLOGY, 1998, 9 : 57 - 57
  • [9] C-MYC, C-ERBB-2, AND KI-67 EXPRESSION IN NORMAL BREAST-TISSUE AND IN INVASIVE AND NONINVASIVE BREAST-CARCINOMA
    PAVELIC, ZP
    PAVELIC, L
    LOWER, EE
    GAPANY, M
    GAPANY, S
    BARKER, EA
    PREISLER, HD
    CANCER RESEARCH, 1992, 52 (09) : 2597 - 2602
  • [10] 髓母细胞瘤Ki67、c-erbB-2的表达分析
    李莹杰
    夏育竹
    张艳梅
    陈英准
    哈尔滨医科大学学报, 2003, (06) : 503 - 504